ESMO Clinical Practice Guidelines: Sarcoma and GIST
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
The 2018 ESMO Clinical Practice Guidelines on gastrointestinal stromal tumours (GIST) and soft tissue and visceral sarcomas have been produced by ESMO in partnership with EURACAN, the European Reference Network for rare adult solid cancers. They aim to provide the standard approach to diagnosis, treatment and survivorship.
The ESMO Clinical Practice Guidelines on Sarcoma and GIST was the result of a consensus conference held every two years which brings together a large group of European experts. Topics covered: Soft tissue and visceral sarcomas, Bone sarcomas and Gastrointestinal stromal tumours.
GIST , Rare Cancers
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published in 2018 – Ann Oncol (2018); 00: 1–11.
Authors: P.G. Casali, N. Abecassis et al., on behalf of the ESMO Guidelines Committee and EURACAN
Soft Tissue Sarcomas , Rare Cancers
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published in 2018 - Ann Oncol (2018); 00: 1–11.
Authors: P.G. Casali, N. Abecassis et al., on behalf of the ESMO Guidelines Committee and EURACAN
Bone Sarcomas , Rare Cancers
Bone Sarcomas: ESMO Clinical Practice Guidelines
Published in 2014 – Ann Oncol (2014) 25 (suppl 3): iii113-iii123.
Authors: The ESMO / European Sarcoma Network Working Group